Clinical Trials

100 enrolled

CNS

Glioblastoma, Glioma

NCT02223923 2025-08-01

Patriot

87 enrolled

Solid Tumour Refractory to Conventional Treatment

NCT02716012 2025-03-10

OUTREACH

75 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms

NCT06497660 2025-03-04

Effect of Neoadjuvant Chemotherapy on Cardiac Function of Perioperative Patients With Breast Cancer and New Strategies for Anesthesia

Phase 4 Unknown

496 enrolled

Breast Neoplasms

NCT06857747 2025-03-04

Disitamab Vedotin in Combination with Metronomic Chemotherapy in Advanced HER2-expressing Breast Cancer.

Breast Neoplasms

NCT06418347 2025-02-24

Effect of ALA Combined With Letrozole on Polycystic Ovary Syndrome Clinical Outcome in Infertile Females

Phase 3 Unknown

150 enrolled

Infertility, Infertility, Female, Polycystic Ovary Syndrome

NCT05599789 2025-02-18

KeyPemls-004

47 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02637479 2025-01-30

Hyporadoul

Any Cancer With Multiple Bone Metastases

NCT06216743 2024-12-31

PRE-MISTIC

15 enrolled

Colonic Neoplasms

NCT06311357 2024-12-27

Percent Weight Change in the Medical Supplement Group of Early Breast Cancer

Early Stage Breast Cancer

NCT06745999 2024-12-24

Cryotherapy in Combination with Red Light PDT for Actinic Keratosis of Full Face

Phase 4 Unknown

Dermatologic

Keratosis, Actinic

NCT06250244 2024-12-11

177Lu-LNC1011 in Patients with Metastatic Castration-resistant Prostate Cancer

Phase 1/2 Unknown

12 enrolled

Metastatic Castration-resistant Prostate Cancer

NCT06724835 2024-12-09

Treating Nectin-4-positive Advanced Breast Cancer with XKDCT293 (Nectin-4-CAR-T)

18 enrolled

Advanced Breast Cancer

NCT06288854 2024-11-21

Efficacy of Olanzapine on Weight Gain in Advanced Gynecologic Cancer with Paclitaxel and Carboplatin: a Double Blind, Placebo-controlled Randomized Trial

48 enrolled

Weight Gain

NCT06678230 2024-11-07

Clinical Trial of Eribulin in Combination with Anrotinib for HER-2 Negative Locally Advanced or Metastatic Breast Cancer

Breast Neoplasms

NCT06659406 2024-10-26

PCOS

30 enrolled

Polycystic Ovary Syndrome

NCT06344923 2024-10-16

Peritoneum and Anterior Rectus Sheath Suturing and Ileostomy

120 enrolled

Rectal Neoplasms

NCT02236910 2024-10-15

Lu-DOTA-TATE

66 enrolled

Endocrine

Carcinoma, Neuroendocrine

NCT06121752 2024-10-15

DNET

54 enrolled

EndocrineNET

Neuroendocrine Tumors

NCT04977167 2024-10-10

Clinical Trial of HG146 Administered to Subjects with Advanced Solid Tumors or Lymphoma

96 enrolled

Lymphoid

Lymphoma

NCT06196762 2024-10-10

Phase I of XKH002 Injection in Patients

110 enrolled

Advanced or Metastatic Solid Tumors

NCT01818323 2024-10-09

Phase I Trial: T4 Immunotherapy of Head and Neck Cancer

30 enrolled

Head & Neck

Head and Neck Neoplasms

NCT06624813 2024-10-03

P-RALP

50 enrolled

Prostatic Neoplasms

NCT05644821 2024-10-01

PRO-P

260 enrolled

Prostatic Neoplasms

NCT06322095 2024-10-01

A Study of GH21 Combined With Previous Target Therapy or Immunotherapy in Patients With Advanced Solid Tumors

72 enrolled

Patients With Advanced Solid Tumor

NCT03310632 2024-09-25

Determine Function of Antroquinonol in Combination With SOC in First Line Metastatic Pancreatic Cancer

Phase 1/2 Unknown

52 enrolled

Pancreatic Neoplasms

NCT05625737 2024-09-19

Fruquintinib Combined with Sintilimab As Second-line Therapy for Gastric or Gastro-esophageal Junction Adenocarcinoma

29 enrolled

Stomach Neoplasms

NCT06586697 2024-09-19

First-line Treatment for ES-SCLC with Chemotherapy Combined with PD-1/PD-L1 Inhibitor Sequential Thoracic Radiotherapy

47 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT06347354 2024-08-27

FLUO

10 enrolled

BreastGastrointestinalThoracic

Breast Neoplasms

NCT05830097 2024-08-26

A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors

Phase 1/2 Unknown

260 enrolled

Breast Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Pancreatic Neoplasms

NCT06022666 2024-08-23

PATH Program for for Severely Frail or Cognitively Impaired Patients Scheduled for Cancer Surgery.

150 enrolled

Frailty, Cognitive Dysfunction

NCT06566391 2024-08-22

Ipilimumab and Nivolumab Followed by Adjuvant Nivolumab in Locally Advanced or Limited Metastatic Melanoma

35 enrolled

Dermatologic

Melanoma

NCT04354233 2024-08-21

ABLE02

244 enrolled

Breast Neoplasms, Fatigue, Motor Activity

NCT05452668 2024-08-21

Laser Therapy Effect on Oral Mucositis in Childhood Acute Lymphoblastic Leukemia Patients

LymphoidOther hematologic neoplasm

51 enrolled

Stomatitis, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06149169 2024-08-21

CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Large B-cell Lymphoma

10 enrolled

Lymphoid

Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT03612232 2024-08-19

CaboACC

37 enrolled

Endocrine

Adrenal Cortex Neoplasms, Adrenal Gland Neoplasms, Adrenocortical Carcinoma

NCT06556004 2024-08-15

Trimelvax001

20 enrolled

Dermatologic

Melanoma

NCT06552650 2024-08-14

Evaluating the Effectiveness of an Early Exercise Program After Breast Reconstruction

72 enrolled

Braest Cancer

NCT06157359 2024-08-09

Effect of SNB on the QoR in Patients Undergoing Supratentorial Tumor Resection

84 enrolled

Supratentorial Neoplasms

NCT06353360 2024-08-09

TTField in Combination With Temozolomide and Tislelizumab in The Treatment of Newly Diagnosed Glioblastoma.

30 enrolled

CNS

Glioblastoma

NCT04922658 2024-07-31

Surufatinib or Surufatinib Combined With Vinorelbine for Non-Small Cell Lung Cancer

60 enrolled

Thoracic

Advanced Non-Small Cell Lung Cancer

NCT06128694 2024-07-30

Effect of NUTRICAN to Improve Nutritional Status in Cancer Patients

Phase 3 Unknown

108 enrolled

GynecologicThoracic

Uterine Cervical Neoplasms, Kwashiorkor, Lung Neoplasms, Neoplasms, Malnutrition

NCT06526832 2024-07-30

A Phase 1 Study of BST02 in Treating Locally Advanced Liver Cancer

9 enrolled

Locally Advanced Liver Carcinoma

NCT06199908 2024-07-26

AMT-562 in Patients With Selected Advanced Solid Tumors

72 enrolled

Advanced Solid Tumors

NCT06237491 2024-07-24

The Safety and Dosimetry Study of 177Lu-LNC1003 Injection

12 enrolled

Metastatic Castration-resistant Prostate Cancer, mCRPC

NCT06256055 2024-07-24

Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors

GastrointestinalGynecologicOther solid neoplasmThoracic

24 enrolled

Mesothelioma, Malignant, Bile Duct Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT06512272 2024-07-22

VOIR

LymphoidOther hematologic neoplasm

60 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03362801 2024-07-19

SAMPHYR

69 enrolled

Urinary Bladder Neoplasms, Motor Activity, Sarcopenia

NCT06507332 2024-07-18

Combination Letrozole and Clomiphene Citrate Versus Letrozole Alone